Olverembatinib for myeloid/lymphoid neoplasm associated with eosinophilia and rearrangement.

Leuk Lymphoma

State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, P.R. China.

Published: September 2023

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2023.2226277DOI Listing

Publication Analysis

Top Keywords

olverembatinib myeloid/lymphoid
4
myeloid/lymphoid neoplasm
4
neoplasm associated
4
associated eosinophilia
4
eosinophilia rearrangement
4
olverembatinib
1
neoplasm
1
associated
1
eosinophilia
1
rearrangement
1

Similar Publications

Olverembatinib for myeloid/lymphoid neoplasm associated with eosinophilia and rearrangement.

Leuk Lymphoma

September 2023

State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, P.R. China.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!